These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8870728)

  • 21. Ethopharmacology; a new way to analyse drug effects on behaviour.
    Dixon AK
    Triangle; 1982; 21(2-3):95-105. PubMed ID: 7164161
    [No Abstract]   [Full Text] [Related]  

  • 22. Affectis Pharmaceuticals AG. Innovative drugs to treat affective disorders.
    van den Brandt S
    Arzneimittelforschung; 2005; 55(8):487-8. PubMed ID: 16149718
    [No Abstract]   [Full Text] [Related]  

  • 23. [Predicting the psychotropic properties of new drugs on the basis of drug screening in animals].
    Kostowski W
    Psychiatr Pol; 1976; 10(1):33-43. PubMed ID: 1250903
    [No Abstract]   [Full Text] [Related]  

  • 24. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An animal test model for evaluating drugs with anti-mass-psychotic activity].
    Lemmingson O; Lüllmann H; Prooter H; de Voss R
    Arzneimittelforschung; 1974 Dec; 24(12):2070-3. PubMed ID: 4480286
    [No Abstract]   [Full Text] [Related]  

  • 26. Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989. Report of the Consensus Committee.
    Amaducci L; Angst J; Bech P; Benkert O; Bruinvels J; Engel RR; Gottfries CG; Hippius H; Levy R; Lingjaerde O
    Pharmacopsychiatry; 1990 Jul; 23(4):171-5. PubMed ID: 2200068
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychoactive drugs, animal ECoG and behaviour.
    Rougeul A
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():559-65. PubMed ID: 6819126
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphoma and behavioral responses to psychomotor drugs.
    Lang JM; Vredevoe DL; Levy L
    Proc West Pharmacol Soc; 1984; 27():455-60. PubMed ID: 6494184
    [No Abstract]   [Full Text] [Related]  

  • 29. The green evolution of psychotropic drugs.
    Briley M; Moret C
    Curr Opin Investig Drugs; 2002 Feb; 3(2):255-6. PubMed ID: 12020056
    [No Abstract]   [Full Text] [Related]  

  • 30. [From gene to behavior, a new method for elaboration of new psychotropic agents].
    Costentin J
    Ann Pharm Fr; 1998; 56(2):60-7. PubMed ID: 9770025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports.
    Alper K; Schwartz KA; Kolts RL; Khan A
    Biol Psychiatry; 2007 Aug; 62(4):345-54. PubMed ID: 17223086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Off-label drug prescriptions].
    Ilku L; Vizi J
    Psychiatr Hung; 2007; 22(1):89-94. PubMed ID: 17642123
    [No Abstract]   [Full Text] [Related]  

  • 33. Individual differences in acute effects of drugs in humans: their relevance to risk for abuse.
    de Wit H
    NIDA Res Monogr; 1998 Mar; 169():176-87. PubMed ID: 9686416
    [No Abstract]   [Full Text] [Related]  

  • 34. 8th congress of the Polish Pharmacological Society. Symposium II: Pharmacological implications for animal models of mental disorders.
    Pol J Pharmacol Pharm; 1984; 36(5):493-569. PubMed ID: 6543467
    [No Abstract]   [Full Text] [Related]  

  • 35. Disposition and action of drugs affecting behavior.
    Maickel RP
    Psychopharmacol Bull; 1975 Apr; 11(2):51. PubMed ID: 1135377
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychoactive drugs and the organization of behavior.
    Norton S
    Psychopharmacol Bull; 1975 Apr; 11(2):54-5. PubMed ID: 1169793
    [No Abstract]   [Full Text] [Related]  

  • 37. [Summary of the podium discussion on the fundamentals and guidelines for preliminary clinical trials of psychopharmaceutics (phase I and II) Oct. 29, 1977].
    Heimann H
    Arzneimittelforschung; 1978; 28(9):1534-6. PubMed ID: 383105
    [No Abstract]   [Full Text] [Related]  

  • 38. Brief review of current research in FXS: implications for treatment with psychotropic medication.
    Valdovinos MG
    Res Dev Disabil; 2007; 28(6):539-45. PubMed ID: 17034990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of psychologic factors in chronic urticaria. When and how?].
    Buffet M
    Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S145-59. PubMed ID: 12843819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated discrimination of psychotropic drugs in mice via computer vision-based analysis.
    Yucel Z; Sara Y; Duygulu P; Onur R; Esen E; Ozguler AB
    J Neurosci Methods; 2009 Jun; 180(2):234-42. PubMed ID: 19464515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.